{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:14:30Z","timestamp":1790615670499,"version":"4.1.0"},"reference-count":106,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":700,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"L'Or\u00e9al Research & Innovation and Beiersdorf"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1111\/bjd.12536","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T10:56:47Z","timestamp":1444733807000},"page":"41-56","source":"Crossref","is-referenced-by-count":123,"special_numbering":"supplement s3","title":["Facial hyperpigmentation: causes and treatment"],"prefix":"10.1093","volume":"169","author":[{"given":"N.A.","family":"Vashi","sequence":"first","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; Boston Medical Center; 609 Albany St J602 Boston MA 02118 U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.V.","family":"Kundu","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Northwestern University Feinberg School of Medicine; 676\u00a0N. St Clair Street Suite 1600 Chicago IL 60611 U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"10.1111\/bjd.12536-BIB0001|bjd12536-cit-0001","unstructured":"U.S. Census Bureau An Older and More Diverse Nation by Midcentury 2008 http:\/\/www.census.gov\/newsroom\/releases\/archives\/population\/cb08-123.html"},{"key":"10.1111\/bjd.12536-BIB0002|bjd12536-cit-0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/C2PP25182E","article-title":"Photodermatoses in pigmented skin","volume":"12","author":"Sharma","year":"2013","journal-title":"Photochem Photobiol Sci"},{"issue":"2 Suppl.","key":"10.1111\/bjd.12536-BIB0003|bjd12536-cit-0003","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1067\/mjd.2002.120790","article-title":"Skin of color: biology, structure, function, and implications for dermatologic disease","volume":"46","author":"Taylor","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0004|bjd12536-cit-0004","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/1971082a0","article-title":"Chemical composition and terminology of specialized organelles (melanosomes and melanin granules) in mammalian melanocytes","volume":"197","author":"Seiji","year":"1963","journal-title":"Nature"},{"key":"10.1111\/bjd.12536-BIB0005|bjd12536-cit-0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/1523-1747.ep12476630","article-title":"Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes","volume":"100","author":"Iozumi","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12536-BIB0006|bjd12536-cit-0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0749.2006.00293.x","article-title":"Diversity of pigmentation in cultured human melanocytes is due to differences in the type as well as quantity of melanin","volume":"19","author":"Wakamatsu","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1111\/bjd.12536-BIB0007|bjd12536-cit-0007","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1073\/pnas.75.11.5395","article-title":"Photodestruction of pheomelanin: role of oxygen","volume":"75","author":"Chedekel","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.12536-BIB0008|bjd12536-cit-0008","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1751-1097.1984.tb08863.x","article-title":"Photoinduced oxygen consumption in melanin systems - II. Action spectra and quantum yields for pheomelanins","volume":"39","author":"Sarna","year":"1984","journal-title":"Photochem Photobiol"},{"issue":"Suppl. 45","key":"10.1111\/bjd.12536-BIB0009|bjd12536-cit-0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajpa.20727","article-title":"Human pigmentation variation: evolution, genetic basis, and implications for public health","volume":"134","author":"Parra","year":"2007","journal-title":"Am J Phys Anthropol"},{"key":"10.1111\/bjd.12536-BIB0010|bjd12536-cit-0010","volume-title":"Mitochondria and Other Cytoplasmic Inclusions","author":"Society for Experimental Biology","year":"1959"},{"key":"10.1111\/bjd.12536-BIB0011|bjd12536-cit-0011","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/2221081a0","article-title":"Racial differences in the fate of melanosomes in human epidermis","volume":"222","author":"Szabo","year":"1969","journal-title":"Nature"},{"key":"10.1111\/bjd.12536-BIB0012|bjd12536-cit-0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jid.1957.4","article-title":"Quantitative and qualitative data on the pigment cells of adult human epidermis","volume":"28","author":"Staricco","year":"1957","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12536-BIB0013|bjd12536-cit-0013","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/newbio236143a0","article-title":"Alteration of racial differences in melanosome distribution in human epidermis after exposure to ultraviolet light","volume":"236","author":"Toda","year":"1972","journal-title":"Nat New Biol"},{"key":"10.1111\/bjd.12536-BIB0014|bjd12536-cit-0014","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0190-9622(91)70148-U","article-title":"The architecture of black and white facial skin","volume":"24","author":"Montagna","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0015|bjd12536-cit-0015","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1524-4725.2011.02065.x","article-title":"Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification","volume":"37","author":"Ranu","year":"2011","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0016|bjd12536-cit-0016","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0190-9622(79)70018-1","article-title":"Photoprotection by melanin - a comparison of black and Caucasian skin","volume":"1","author":"Kaidbey","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0017|bjd12536-cit-0017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0190-9622(83)70060-5","article-title":"Pigmentary incontinence in fixed drug eruptions. Histologic and electron microscopic findings","volume":"8","author":"Masu","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0018|bjd12536-cit-0018","volume-title":"Dermatology","year":"2012","edition":"3"},{"issue":"6 Suppl.","key":"10.1111\/bjd.12536-BIB0019|bjd12536-cit-0019","first-page":"2","article-title":"Natural considerations for skin of color","volume":"78","author":"Baumann","year":"2006","journal-title":"Cutis"},{"key":"10.1111\/bjd.12536-BIB0020|bjd12536-cit-0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/0974-2077.101373","article-title":"Idiopathic cutaneous hyperchromia at the orbital region or periorbital hyperpigmentation","volume":"5","author":"Sarkar","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1111\/bjd.12536-BIB0021|bjd12536-cit-0021","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1524-4725.2009.01213.x","article-title":"Infraorbital dark circles: definition, causes, and treatment options","volume":"35","author":"Roh","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0022|bjd12536-cit-0022","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0378-6323.34009","article-title":"Periorbital melanosis is an extension of pigmentary demarcation line-F on face","volume":"73","author":"Malakar","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.12536-BIB0023|bjd12536-cit-0023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0974-2077.101371","article-title":"Determination of melanin and haemoglobin in the skin of idiopathic cutaneous hyperchromia of the orbital region (ICHOR): a study of Indian patients","volume":"5","author":"Verschoore","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1111\/bjd.12536-BIB0024|bjd12536-cit-0024","first-page":"785","article-title":"Condition known as \u2018dark rings under the eyes\u2019 in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser","volume":"32","author":"Watanabe","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0025|bjd12536-cit-0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4103\/0378-6323.84046","article-title":"Facial melanoses: Indian perspective","volume":"77","author":"Khanna","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.12536-BIB0026|bjd12536-cit-0026","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","article-title":"Melasma: a comprehensive update: part I","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0027|bjd12536-cit-0027","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00128071-200102040-00002","article-title":"Exogenous ochronosis. An update on clinical features, causative agents and treatment options","volume":"2","author":"Levin","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.12536-BIB0028|bjd12536-cit-0028","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaad.2007.02.020","article-title":"The safety of hydroquinone: a dermatologist's response to the 2006 Federal Register","volume":"57","author":"Levitt","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0029|bjd12536-cit-0029","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1473-2130.2004.00089.x","article-title":"Exogenous ochronosis following hydroquinone for melasma","volume":"3","author":"Zawar","year":"2004","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.12536-BIB0030|bjd12536-cit-0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-4632.2007.03351.x","article-title":"Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy","volume":"47","author":"Charlin","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0031|bjd12536-cit-0031","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1468-3083.2008.02931.x","article-title":"Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream","volume":"23","author":"Adigun","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12536-BIB0032|bjd12536-cit-0032","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaad.2006.08.016","article-title":"Juvenile acanthosis nigricans","volume":"57","author":"Sinha","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0033|bjd12536-cit-0033","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1524-4725.2000.0260111000.x","article-title":"A retrospective analysis of complications in the treatment of nevus of Ota with the Q-switched alexandrite and Q-switched Nd:YAG lasers","volume":"26","author":"Chan","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0034|bjd12536-cit-0034","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1524-4725.2000.026010919.x","article-title":"An in vivo trial comparing the clinical efficacy and complications of Q-switched 755\u00a0nm alexandrite and Q-switched 1064\u00a0nm Nd:YAG lasers in the treatment of nevus of Ota","volume":"26","author":"Chan","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0035|bjd12536-cit-0035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(84)80313-8","article-title":"Acquired, bilateral nevus of Ota-like macules","volume":"10","author":"Hori","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0036|bjd12536-cit-0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00042728-200601000-00006","article-title":"Treatment of acquired bilateral nevus of ota-like macules (Hori's nevus) with a combination of the 532\u00a0nm Q-Switched Nd:YAG laser followed by the 1,064\u00a0nm Q-switched Nd:YAG is more effective: prospective study","volume":"32","author":"Ee","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0037|bjd12536-cit-0037","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-4632.2008.04061.x","article-title":"Treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) using 1064-nm Q-switched Nd:YAG laser with low fluence","volume":"48","author":"Cho","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0038|bjd12536-cit-0038","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.2910620402","article-title":"Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE)","volume":"62","author":"Bliss","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.12536-BIB0039|bjd12536-cit-0039","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/1097-0142(19910401)67:7<1990::AID-CNCR2820670728>3.0.CO;2-P","article-title":"Sun-induced freckles in children and young adults. A correlation of clinical and histopathologic features","volume":"67","author":"Rhodes","year":"1991","journal-title":"Cancer"},{"key":"10.1111\/bjd.12536-BIB0040|bjd12536-cit-0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0190-9622(83)70106-4","article-title":"The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes","volume":"9","author":"Rhodes","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0041|bjd12536-cit-0041","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-4632.2004.02001.x","article-title":"Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis","volume":"43","author":"Schwartz","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0042|bjd12536-cit-0042","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2230.2003.01367.x","article-title":"A study of 124 Indian patients with lichen planus pigmentosus","volume":"28","author":"Kanwar","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12536-BIB0043|bjd12536-cit-0043","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1468-3083.2009.03460.x","article-title":"Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study","volume":"24","author":"Al-Mutairi","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12536-BIB0044|bjd12536-cit-0044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1346-8138.2011.01233.x","article-title":"Linear lichen planus pigmentosus of the forehead treated by neodymium:yttrium-aluminum-garnet laser and topical tacrolimus","volume":"39","author":"Kim","year":"2012","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0045|bjd12536-cit-0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.arcped.2007.10.020","article-title":"Childhood actinic lichen planus (6 cases)","volume":"15","author":"Dammak","year":"2008","journal-title":"Arch Pediatr"},{"key":"10.1111\/bjd.12536-BIB0046|bjd12536-cit-0046","first-page":"377","article-title":"Lichen planus actinicus","volume":"72","author":"Meads","year":"2003","journal-title":"Cutis"},{"key":"10.1111\/bjd.12536-BIB0047|bjd12536-cit-0047","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1111\/j.1440-0960.2010.00695.x","article-title":"Childhood actinic lichen planus: successful treatment with antimalarials","volume":"53","author":"Ramirez","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0048|bjd12536-cit-0048","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2230.2007.02638.x","article-title":"An observational analysis of erythromelanosis follicularis faciei et colli","volume":"33","author":"Sardana","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12536-BIB0049|bjd12536-cit-0049","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-4632.2008.03478.x","article-title":"Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India","volume":"47","author":"Inamadar","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0050|bjd12536-cit-0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00128071-200001050-00001","article-title":"Management of facial hyperpigmentation","volume":"1","author":"Perez-Bernal","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.12536-BIB0051|bjd12536-cit-0051","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1473-2165.2007.00321.x","article-title":"Hyperpigmentation and melasma","volume":"6","author":"Rigopoulos","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.12536-BIB0052|bjd12536-cit-0052","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2011.06.001","article-title":"Melasma: a comprehensive update: part II","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0053|bjd12536-cit-0053","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/jid.1962.136","article-title":"Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light","volume":"39","author":"Pathak","year":"1962","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12536-BIB0054|bjd12536-cit-0054","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1751-1097.2007.00286.x","article-title":"Effects of visible light on the skin","volume":"84","author":"Mahmoud","year":"2008","journal-title":"Photochem Photobiol"},{"key":"10.1111\/bjd.12536-BIB0055|bjd12536-cit-0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1523-1747.ep12701679","article-title":"Mechanism of depigmentation by hydroquinone","volume":"62","author":"Jimbow","year":"1974","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12536-BIB0056|bjd12536-cit-0056","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0749.2003.00029.x","article-title":"Chemical and instrumental approaches to treat hyperpigmentation","volume":"16","author":"Briganti","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1111\/bjd.12536-BIB0057|bjd12536-cit-0057","first-page":"761","volume-title":"Comprehensive Dermatologic Drug Therapy","author":"Draelos","year":"2007","edition":"2"},{"key":"10.1111\/bjd.12536-BIB0058|bjd12536-cit-0058","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/09546630050517333","article-title":"A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma","volume":"11","author":"Ennes","year":"2000","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12536-BIB0059|bjd12536-cit-0059","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-4362.1998.00499.x","article-title":"Topical hydroquinone in the treatment of some hyperpigmentary disorders","volume":"37","author":"Amer","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0060|bjd12536-cit-0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1473-2165.2005.40202.x","article-title":"Hydroquinone and its analogues in dermatology - a potential health risk","volume":"4","author":"Westerhof","year":"2005","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.12536-BIB0061|bjd12536-cit-0061","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1468-3083.2006.01670.x","article-title":"The safety of hydroquinone","volume":"20","author":"Nordlund","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12536-BIB0062|bjd12536-cit-0062","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-4362.1991.tb04362.x","article-title":"The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream","volume":"30","author":"Balina","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0063|bjd12536-cit-0063","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1529-8019.2006.00085.x","article-title":"Retinoid therapy of pigmentary disorders","volume":"19","author":"Ortonne","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1111\/bjd.12536-BIB0064|bjd12536-cit-0064","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","article-title":"Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial","volume":"130","author":"Kimbrough-Green","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12536-BIB0065|bjd12536-cit-0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1993.tb03169.x","article-title":"Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial","volume":"129","author":"Griffiths","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0066|bjd12536-cit-0066","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1346-8138.2002.tb00324.x","article-title":"Adapalene in the treatment of melasma: a preliminary report","volume":"29","author":"Dogra","year":"2002","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0067|bjd12536-cit-0067","first-page":"45","article-title":"Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study","volume":"77","author":"Grimes","year":"2006","journal-title":"Cutis"},{"key":"10.1111\/bjd.12536-BIB0068|bjd12536-cit-0068","first-page":"549","article-title":"Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris","volume":"9","author":"Tanghetti","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.12536-BIB0069|bjd12536-cit-0069","first-page":"868","article-title":"Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial","volume":"82","author":"Leenutaphong","year":"1999","journal-title":"J Med Assoc Thai (Chotmaihet Thangphaet)"},{"key":"10.1111\/bjd.12536-BIB0070|bjd12536-cit-0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(00)90219-6","article-title":"The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies","volume":"42","author":"Fleischer","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0071|bjd12536-cit-0071","first-page":"319","article-title":"Mequinol 2%\/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines","volume":"74","author":"Jarratt","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/bjd.12536-BIB0072|bjd12536-cit-0072","first-page":"179","article-title":"Mequinol 2%\/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature","volume":"81","author":"Keeling","year":"2008","journal-title":"Cutis"},{"key":"10.1111\/bjd.12536-BIB0073|bjd12536-cit-0073","first-page":"147","article-title":"A promising new treatment for solar lentigines","volume":"2","author":"Colby","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.12536-BIB0074|bjd12536-cit-0074","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00018-005-5054-y","article-title":"Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future","volume":"62","author":"Kim","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/bjd.12536-BIB0075|bjd12536-cit-0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","article-title":"Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid","volume":"25","author":"Lim","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0076|bjd12536-cit-0076","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1524-4725.1996.tb00345.x","article-title":"The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.12536-BIB0077|bjd12536-cit-0077","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1529-8019.2007.00144.x","article-title":"Skin lightening preparations and the hydroquinone controversy","volume":"20","author":"Draelos","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1111\/bjd.12536-BIB0078|bjd12536-cit-0078","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-4632.2004.02134.x","article-title":"A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma","volume":"43","author":"Espinal-Perez","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0079|bjd12536-cit-0079","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2310\/7750.2008.07092","article-title":"Clinical efficacy of 25% l-ascorbic acid (C'ensil) in the treatment of melasma","volume":"13","author":"Hwang","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/bjd.12536-BIB0080|bjd12536-cit-0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1751-1097.1996.tb02447.x","article-title":"Protective effect of magnesium-l-ascorbyl-2 phosphate against skin damage induced by UVB irradiation","volume":"64","author":"Kobayashi","year":"1996","journal-title":"Photochem Photobiol"},{"key":"10.1111\/bjd.12536-BIB0081|bjd12536-cit-0081","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0190-9622(96)90830-0","article-title":"Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo","volume":"34","author":"Kameyama","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0082|bjd12536-cit-0082","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0749.1998.tb00494.x","article-title":"The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation","volume":"11","author":"Yokota","year":"1998","journal-title":"Pigment Cell Res"},{"key":"10.1111\/bjd.12536-BIB0083|bjd12536-cit-0083","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-4362.2000.00943.x","article-title":"Topical liquiritin improves melasma","volume":"39","author":"Amer","year":"2000","journal-title":"Int J Dermatol"},{"issue":"5 Suppl. 2","key":"10.1111\/bjd.12536-BIB0084|bjd12536-cit-0084","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaad.2005.12.039","article-title":"Treatment of melasma","volume":"54","author":"Rendon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12536-BIB0085|bjd12536-cit-0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/excr.1999.4692","article-title":"The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions","volume":"254","author":"Seiberg","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1111\/bjd.12536-BIB0086|bjd12536-cit-0086","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2001.01291.x","article-title":"An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway","volume":"116","author":"Paine","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12536-BIB0087|bjd12536-cit-0087","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000063359","article-title":"Assessment of topical hypopigmenting agents on solar lentigines of Asian women","volume":"204","author":"Hermanns","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12536-BIB0088|bjd12536-cit-0088","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2133.2008.08864.x","article-title":"Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives","volume":"159","author":"Chawla","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0089|bjd12536-cit-0089","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.0906-6705.2005.00337.x","article-title":"DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency","volume":"14","author":"Boissy","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12536-BIB0090|bjd12536-cit-0090","first-page":"291","article-title":"Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent","volume":"57","author":"Hamed","year":"2006","journal-title":"J Cosmet Sci"},{"key":"10.1111\/bjd.12536-BIB0091|bjd12536-cit-0091","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.0906-6705.2005.00309.x","article-title":"Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible","volume":"14","author":"Greatens","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12536-BIB0092|bjd12536-cit-0092","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","article-title":"The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer","volume":"147","author":"Hakozaki","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0093|bjd12536-cit-0093","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.0909-752X.2006.00186.x","article-title":"Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide","volume":"12","author":"Hakozaki","year":"2006","journal-title":"Skin Res Technol"},{"key":"10.1111\/bjd.12536-BIB0094|bjd12536-cit-0094","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1473-2165.2007.00339.x","article-title":"Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro","volume":"6","author":"Bissett","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.12536-BIB0095|bjd12536-cit-0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2133.2009.09477.x","article-title":"Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial","volume":"162","author":"Kimball","year":"2010","journal-title":"Br J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/bjd.12536-BIB0096|bjd12536-cit-0096","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0625.12.s2.7.x","article-title":"The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells","volume":"12","author":"Usuki","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12536-BIB0097|bjd12536-cit-0097","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-4632.2003.02017.x","article-title":"Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma","volume":"42","author":"Guevara","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0098|bjd12536-cit-0098","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1473-2165.2011.00581.x","article-title":"A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream","volume":"10","author":"Mauricio","year":"2011","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.12536-BIB0099|bjd12536-cit-0099","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archderm.1991.01680090092011","article-title":"N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma","volume":"127","author":"Jimbow","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12536-BIB0100|bjd12536-cit-0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archderm.1975.01630130042004","article-title":"A new formula for depigmenting human skin","volume":"111","author":"Kligman","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12536-BIB0101|bjd12536-cit-0101","first-page":"1","article-title":"Topical treatments for melasma and postinflammatory hyperpigmentation","volume":"11","author":"Lynde","year":"2006","journal-title":"Skin Therapy Lett"},{"key":"10.1111\/bjd.12536-BIB0102|bjd12536-cit-0102","first-page":"57","article-title":"Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"key":"10.1111\/bjd.12536-BIB0103|bjd12536-cit-0103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1473-2165.2007.00288.x","article-title":"A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma","volume":"6","author":"Ferreira Cestari","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.12536-BIB0104|bjd12536-cit-0104","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1365-4362.2001.01167-2.x","article-title":"Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid","volume":"40","author":"Guevara","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12536-BIB0105|bjd12536-cit-0105","first-page":"153","article-title":"Cost-effectiveness of a fixed combination of hydroquinone\/tretinoin\/fluocinolone cream compared with hydroquinone alone in the treatment of melasma","volume":"6","author":"Cestari","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.12536-BIB0106|bjd12536-cit-0106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002660010107","article-title":"Dermabrasion: a curative treatment for melasma","volume":"25","author":"Kunachak","year":"2001","journal-title":"Aesthetic Plast Surg"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12536","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12536\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:06:34Z","timestamp":1718132794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/169\/s3\/41\/6614759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":106,"URL":"https:\/\/doi.org\/10.1111\/bjd.12536","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}